YY/T 1550.2-2019Guidance on the study of compatibility between infusion equipment and pharmaceutical products - Part 2: Leachables - Known substances (English PDF)
一次性使用输液器具与药物相容性研究指南 第2部分:可沥滤物研究 已知物
This is a limited preview
Buy now to download the full PDF (18 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1550.2-2019 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
July 24, 2019
Implementation date
August 1, 2020
Scope
YY/T 1550.2-2019 is the English-translated version of 一次性使用输液器具与药物相容性研究指南 第2部分:可沥滤物研究 已知物.
YY/T 1550.2-2019 is the Chinese pharmaceutical industry standard that describes how to study the known leachable substances released when single-use infusion equipment is in contact with a drug, under clinical infusion conditions or conditions that simulate them.
It explains how to prepare the extract liquid, either with the drug itself, following the dosage, infusion carrier, dilution, infusion method, rate and temperature of clinical practice, or with an alternative simulated solvent chosen after demonstration.
For the determination itself it sets out the methodological work to be done - specificity, linear range, detection and quantitation limits, precision and accuracy - and points to HPLC, LC-MS, GC-MS, GC, AAS and ICP-MS as the usual analytical methods.
It also states what the study report must contain. Issued on 24 July 2019, it has applied since 1 August 2020.
Found what you need?
Document preview — YY/T 1550.2-2019
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- Introduction4
- 1 Scope5
- 2 Normative references5
- 3 Terms and definitions5
- 4 Test methods6
- 5 Content of study report9
1 Scope
This Part of YY/T 1550 gives the method for study on known leachable substance in the process of single-use infusion equipment in contact with pharmaceutical products under clinical infusion conditions or simulated clinical actual infusion conditions.
This Part applies to the study of known leachable substance with specific infusion equipment and pharmaceutical product to be infused or a simulated solvent selected after demonstration.
2 Normative references
The following documents are indispensable for the application of this document.
For the dated references, only the editions with the dates indicated are applicable to this document. For the undated references, the latest edition (including all the amendments) are applicable to this document.
GB/T 16886.12-2017 Biological evaluation of medical devices - Part 12:
Sample preparation and reference materials Pharmacopeia of the People's Republic of China (2015)
3 Terms and definitions
The following terms and definitions apply to this document.
3.1 Leachable substance
The substance which can be released from a medical device or material during clinical use.
[GB/T 16886.12-2017, definition 3.10]
4.1.2 Methods for preparation of extract liquid
4.1.2.1 Preparation of extract liquid using drug
Take the equipment and drugs to be studied; according to the common infusion method given in the drug instruction manual or clinical investigation, prepare the extract liquid. Preparation parameters need to consider the dosage, infusion carrier (such as sodium chloride injection, glucose injection, etc.), dilution method, infusion method (such as gravity drip, infusion pump administration, administration from injection parts) , infusion rate, infusion temperature. If necessary, use clinically applicable infusion carrier to prepare 3 parts of drug infusion liquid in line with clinical practice. Among which, infuse 2 of the infusion liquids through the infusion equipment according to the common infusion methods given in the drug instruction manual or clinical investigation; collect the effluent as the test solution. Another prepared drug infusion liquid is stored under the same conditions for the same time as the drug control solution.
4.1.2.2 Preparation of extract liquid using alternative solvents
If simulated-use extraction is performed, it shall comprehensively consider the parameters and conditions of the medical device in actual clinical use, such as time, temperature, mode of action, etc. First, the preparation method of extract liquid shall be demonstrated, to prove that the extraction conditions selected by the device represent the greatest risk to the patient in the intended use of the product. The selection of simulated solvent shall comprehensively consider other characteristics such as the polarity and pH of the device to be studied in clinical contact with pharmaceutical product.
4.2 Study on known leachable substance
4.2.1 Methodological investigation items
4.2.1.1 Overview
Confirmed test methods should be used to determine known substances in leachables. Generally, methods recommended by national standards or industry standards or methods of determination that have been peer-reviewed are preferred. At present, the commonly-used analytical methods mainly include HPLC, LC-MS, GC-MS, GC, AAS, and ICP-MS. The first four methods are mainly used to evaluate organic leachable substance. The latter two methods are mainly used for the qualitative and quantitative determination of inorganic migratory substances, especially metal elements.
4.2.1.2 Specificity
Excipients in pharmaceutical preparations, related substances, infusion carriers in the preparation of extract liquid, and potential soluble substances in infusion equipment may interfere with the determination of the dissolution amount of the analyte. Appropriate methods should be used to verify specificity.
4.2.1.3 Linear range
Linearity refers to the degree to which the measured response value is proportional to the concentration of the analyte in the sample within the designed range. The range refers to the range of high-low concentrations or quantities when the analytical method can achieve certain precision, accuracy and linearity requirements. The selected method shall ensure that the concentration in the sample to be tested is within its linear range. At the same time, the setting of the range shall consider the toxicological evaluation value.
It is recommended to use at least 5 concentrations.
4.2.1.4 Detection limit
The detection limit refers to the minimum amount of the analyte in the sample that can be detected. The detection limit of the method shall meet the requirements of toxicological evaluation value of the analyte. Appropriate methods shall be used to examine the detection limit. It shall meet the requirements of its toxicological evaluation value. The evaluation method should be carried out in accordance with "Pharmacopeia of the People's Republic of China" (2015) Volume IV 9101.
4.2.1.5 Quantitation limit
The quantification limit refers to the minimum amount of the analyte in the sample that can be quantitatively determined. The determination results shall meet the requirements of accuracy and precision. Appropriate methods shall be used to examine the quantification limit. The evaluation method should be carried out in accordance with "Pharmacopeia of the People's Republic of China" (2015) Volume IV 9101.
4.2.1.6 Precision
Appropriate methods should be used to examine the precision of the proposed method for determination of the content. The evaluation method should be carried out in accordance with "Pharmacopeia of the People's Republic of China" (2015) Volume IV 9101.
4.2.1.7 Accuracy
Appropriate methods should be used to verify the accuracy of the results. Take the standard-addition recovery test as an example; add a quantitative standard substance to the blank sample matrix without the tested substance; according
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 18 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1550.2-2019
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.12-2017 — Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
YY/T 1550.3-2024 — Guidance on the study of compatibility of infusion equipment and pharmaceutical products - Part 3: Leachable study - Unknown substances
YY/T 1550.1-2017 — Guidance of study on the compatibility of infusion equipments and pharmaceutical products - Part 1: Drug sorption
Secure payment via Stripe
Payments accepted
YY/T 1550.2-2019
$90.00